Neuren Pharmaceuticals Ltd (NEU) - Total Liabilities

Latest as of June 2025: AU$7.98 Million AUD ≈ $5.64 Million USD

Based on the latest financial reports, Neuren Pharmaceuticals Ltd (NEU) has total liabilities worth AU$7.98 Million AUD (≈ $5.64 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Neuren Pharmaceuticals Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Neuren Pharmaceuticals Ltd - Total Liabilities Trend (2000–2024)

This chart illustrates how Neuren Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. See NEU free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Neuren Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Neuren Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
FLEX LNG Ltd NYSE:FLNG	USA	$1.90 Billion
Lao Feng Xiang Co Ltd A SHG:600612	China	CN¥8.31 Billion
Gas Malaysia Bhd KLSE:5209	Malaysia	RM2.13 Billion
Klabin S.A SA:KLBN3	Brazil	R$46.51 Billion
Fortress Income Fund Ltd JSE:FFB	South Africa	ZAC28.10 Billion
China Cinda Asset Management Co., Ltd. F:0CI	Germany	€1.50 Trillion
Robertet SA PA:RBT	France	€399.53 Million
Corporate Travel Management Ltd AU:CTD	Australia	AU$354.79 Million

Liability Composition Analysis (2000–2024)

This chart breaks down Neuren Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NEU stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	40.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.75	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuren Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuren Pharmaceuticals Ltd (2000–2024)

The table below shows the annual total liabilities of Neuren Pharmaceuticals Ltd from 2000 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$45.80 Million ≈ $32.41 Million	+7.11%
2023-12-31	AU$42.76 Million ≈ $30.26 Million	+2448.45%
2022-12-31	AU$1.68 Million ≈ $1.19 Million	+108.97%
2021-12-31	AU$803.00K ≈ $568.17K	+6.64%
2020-12-31	AU$753.00K ≈ $532.80K	+34.70%
2019-12-31	AU$559.00K ≈ $395.53K	-71.67%
2018-12-31	AU$1.97 Million ≈ $1.40 Million	+24.87%
2017-12-31	AU$1.58 Million ≈ $1.12 Million	-22.05%
2016-12-31	AU$2.03 Million ≈ $1.43 Million	-18.98%
2015-12-31	AU$2.50 Million ≈ $1.77 Million	-17.37%
2014-12-31	AU$3.03 Million ≈ $2.14 Million	+47.13%
2013-12-31	AU$2.06 Million ≈ $1.46 Million	-3.89%
2012-12-31	AU$2.14 Million ≈ $1.52 Million	+27.20%
2011-12-31	AU$1.68 Million ≈ $1.19 Million	-22.90%
2010-12-31	AU$2.18 Million ≈ $1.55 Million	-25.64%
2009-12-31	AU$2.94 Million ≈ $2.08 Million	-1.19%
2008-12-31	AU$2.97 Million ≈ $2.10 Million	-57.76%
2007-12-31	AU$7.04 Million ≈ $4.98 Million	+108.31%
2006-12-31	AU$3.38 Million ≈ $2.39 Million	+10.88%
2005-12-31	AU$3.05 Million ≈ $2.16 Million	-27.41%
2004-12-31	AU$4.20 Million ≈ $2.97 Million	-72.78%
2003-12-31	AU$15.41 Million ≈ $10.91 Million	+921.40%
2002-12-31	AU$1.51 Million ≈ $1.07 Million	-91.01%
2001-12-31	AU$16.78 Million ≈ $11.87 Million	+120.34%
2000-12-31	AU$7.62 Million ≈ $5.39 Million	--

About Neuren Pharmaceuticals Ltd

AU:NEU Australia Biotechnology

Market Cap

$1.67 Billion

AU$2.35 Billion AUD

Market Cap Rank

#6742 Global

#157 in Australia

Share Price

AU$18.59

Change (1 day)

+3.28%

52-Week Range

AU$11.28 - AU$21.98

All Time High

AU$25.11